Insulet Corporation (PODD)

Basic

  • Market Cap

    $13.34B

  • EV

    $14.13B

  • Shares Out

    69.83M

  • Revenue

    $1,557M

  • Employees

    2,600

Margins

  • Gross

    62.2%

  • EBITDA

    10.13%

  • Operating

    5.62%

  • Pre-Tax

    8.29%

  • Net

    7.71%

  • FCF

    2.6%

Returns (5Yr Avg)

  • ROA

    2.59%

  • ROE

    3.13%

  • ROCE

    4.72%

  • ROIC

    5.87%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $234.52

  • P/E

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $685.4M

  • Net Debt

    $790.6M

  • Debt/Equity

    2.43

  • EBIT/Interest

    2.26

Growth (CAGR)

  • Rev 3Yr

    21.52%

  • Rev 5Yr

    24.08%

  • Rev 10Yr

    20.74%

  • Dil EPS 3Yr

    57.23%

  • Dil EPS 5Yr

    49.4%

  • Dil EPS 10Yr

    5.45%

  • Rev Fwd 2Yr

    23.06%

  • EBITDA Fwd 2Yr

    25.15%

  • EPS Fwd 2Yr

    39.75%

  • EPS LT Growth Est

    34.56%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '13

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

LTM

Total Revenues

563.8

738.2

904.4

1,098.8

1,305.3

1,557

Total Revenues % Chg.

21.6%

30.9%

22.5%

21.5%

18.8%

25.2%

Cost of Goods Sold, Total

193.6

257.9

322.1

346.7

499.7

588.5

Gross Profit

370.2

480.3

582.3

752.1

805.6

968.5

Selling General & Admin Expenses, Total

248

298

384

466

562.6

668.5

R&D Expenses

94.8

132.3

146.8

160.1

180.2

212.5

Other Operating Expenses, Total

342.8

430.3

530.8

626.1

742.8

881

Operating Income

27.4

50

51.5

126

62.8

87.5

Interest Expense, Total

-28.9

-34.6

-48.1

-61.7

-36.5

-38.7

Interest And Investment Income

7.6

6.9

3

0.5

9.8

28.9

Net Interest Expenses

-21.3

-27.7

-45.1

-61.2

-26.7

-9.8

Currency Exchange Gains (Loss)

1

-0.6

3.2

-2

-1.3

-1.3

Other Non Operating Income (Expenses)

-1.9

1.5

0.1

0.1

0.2

3.1

EBT, Excl. Unusual Items

5.2

23.2

9.7

62.9

35

79.5

Asset Writedown

Legal Settlements

-25.2

2.1

Other Unusual Items

-8.7

-42.4

47.5

EBT, Incl. Unusual Items

5.2

14.5

9.7

20.5

9.8

129.1

Income Tax Expense

1.9

2.9

2.9

3.7

5.2

9.1

Earnings From Continuing Operations

3.3

11.6

6.8

16.8

4.6

120

Earnings Of Discontinued Operations

Net Income

3.3

11.6

6.8

16.8

4.6

120

Net Income to Common Incl Extra Items

3.3

11.6

6.8

16.8

4.6

120

Net Income to Common Excl. Extra Items

3.3

11.6

6.8

16.8

4.6

120

Total Shares Outstanding

59.2

62.7

66

69.2

69.5

69.8

Weighted Avg. Shares Outstanding

58.9

60.6

64.7

67.7

69.4

69.7

Weighted Avg. Shares Outstanding Dil

61

62.3

65.9

68.6

69.9

70.5

EPS

0.1

0.2

0.1

0.2

0.1

1.7

EPS Diluted

0.1

0.2

0.1

0.2

0.1

1.7

EBITDA

43

77.9

106.9

183.4

126

157.7